From the Mises Blog, 5/31/2006. Archived comments below.
I’ve pointed out before (2, 3) that the utilitarian logic behind patents—that it’s needed to provide “incentives” to innovate—could also be used to justify taxpayed-funded subsidies to artists and inventors. Interestingly, the World Health Organization, in a recent report,1 points out the damage pharmaceutical patents pose to the poor in the developing world, and also notes that the incentive effect of IP in such countries, in these markets at least, may be limited or non-existent.
Here we have a quasi-governmental bureaucracy—which appears, not surprisingly, to advocate using government-funding to spur innovation—admitting that patents are not only not useful, but probably harmful, in the case of pharmaceuticals.
Ironically, even among those libertarian skeptics of IP, many of them claim that if a case can be made for patents, it is in the field of pharmaceuticals. Tsk Tsk.
Comments (25)
- See the Patent Baristas post; and these WHO reports: World Health Assembly concludes; makes key decisions affecting global public health (May 27, 2006); Public health: Innovation and Intellectual Property Rights: Report of the Commission on Intellectual Property Rights, Innovation and Public Health (April 2006; 2); Commission on Intellectual Property Rights, Innovation and Public Health: report; Commission on Intellectual Property Rights, Innovation and Public Health (CIPIH). [↩]
Published: May 31, 2006 3:53 PM
Sure, just like non-utilitarian arguments can and have been used to justify usury laws. Those arguments are *wrong* on a non-utilitarian basis, just as the case for government subsidies is wrong on a utilitarian basis. (Of course, I think you mean consequentialist.)
Interestingly, the World Health Organization, in a recent report, points out the damage pharmaceutical patents pose to the poor in the developing world, and also notes that the incentive effect of IP in such countries, in these markets at least, may be limited or non-existent.
Oh well, if the WHO says it…
I think I can safely guess without looking that the WHO didn’t account for the drugs that would simply not exist but for the profit-driven search for drugs. One more realistic (though not certain) way of making money from these poorer areas is to give away the drug for free while speculating in real estatein that area. If it increases population pressures, you could profit this way. I actually think Kinsella was given a paper a while ago suggesting exactly this.
Yancey_Ward:
I work as a pharmaceutical chemist and concede the point that IP in pharmaceuticals is not needed as long as you get rid of the FDA at the same time.
Sure, just as long as you can maintain an ironclad Omerta (code of silence) among those who know any part of the formula (and could thus give it away and destroy the value of 20 years and billions of dollars of research), or have everyone who does know the secret purchase an insurance policy worth billions of dollars. Neither of those sounds realistic.
To everyone following Kinsella’s other thread: I’ll get to you, don’t worry, regardless of how non-deserving you are of a response. It’s just that they started a rule on the blog limiting post frequency.
Published: May 31, 2006 4:35 PM
Published: May 31, 2006 5:11 PM
Our current system seems to promote illness.
Published: May 31, 2006 5:54 PM
I for one, am in support of this group of people deciding for society, what is needed, and what laws are necessary to force everyone else to make it happen.
Published: May 31, 2006 7:29 PM
Published: May 31, 2006 7:59 PM
There’s a lot of people way more productive and inventive than you who are vehelmently opposed to the very notion of “intellectual property”.
In fact, it seems that nearly all most important inventions were made by the people who just didn’t care for owning the results – and did it because it was fun.
Published: May 31, 2006 11:11 PM
How is the “Slaves are a property because their masters shiped them over at great financial risk” any different than the “Patents are a property because their holders subsidized heavy R&D;” arguemnt?
I don’t think most people understand that securing patent “rights” requires a certain type of physical control. Just as the commoditisation of the labor force pre-destined the violent death of the plantation system, and the commoditisation of information today is leading to the death of the media and music copyright industries, eventually rapid-prototyping and nano technology are going to bring production into the home and commoditize that. The death of the patnet system will be violent because it is baised off of physical control that must almost be total to work out in the “replication” age. It will likely cost billions of lives to break free from that control.
I also want to note that the US Civil War was the “bloodiest” war in history. More bloody that WW1, WW2, Vietnam, and Iraq. Why? Because they had recently developed all these new technological ways of killing people, but had not developed any countermeasures yet.
Another thing people should consider are the times when patents failed. Like when IBM assumed that they had the right to control the PC interface with their patents. When they lost in court, it created an nuclear explosion of business and commerce in the PC industry and the IBM compatable PC has lasted to this day.
Published: June 1, 2006 12:08 AM
And before one starts citing to years of research and billions of dollars, one should at least try to understand the point Yancey makes, and how that impacts drug research costs. Eliminate that, and your consequentialist argument loses what little traction it had to begin with.
Yancey –
absolutely. The FDA, AMA, and patents all work to distort our medical care market in such massive ways that discussing any single one as a “cure” to the problems we see is naive, at best.
Published: June 1, 2006 7:34 AM
David_C: Wow, you already got to Godwin.
quasibill:
Actually, from the ones I see them mention, they all would exist without the profit driven search for drugs. You see, most of the non-lifestyle drugs are “discovered” by university research laboratories, funded by charity and the government.
If they were funded by charity, they would not assert a patent (and the WHO wouldn’t be griping about the patent). If they were funded by government, it does not follow that they didn’t result from patents. Before the Bayh-Dole Act, government-funded university research was noticed to be a tad sluggish, so to give them some incentive, they allowed such research to be patented. The incentivizing of this effect is hard to measure, but you can’t just assert that it’s zero.
And before one starts citing to years of research and billions of dollars, one should at least try to understand the point Yancey makes, and how that impacts drug research costs. Eliminate that, and your consequentialist argument loses what little traction it had to begin with.
Yancey didn’t make a point, just asserted that patents inhibit innovation, and the FDA drives up cost. Drugs require a significant investment, and would even if there were no FDA. Unless you can keep on Omerta (or buy an impossible insurance policy), you will lose the overwhelming majority of that investment.
Published: June 1, 2006 8:40 AM
3) This extra research leads to drugs being developed sooner than they would otherwise, which ostensibly will lead to more people being helped by drug therapy
Therefore, we have a utilitarian case to justify the initiation of force (or threat thereof), to keep the drug market from being fully free.
Isn’t that your position? How did I take it out of context?
Published: June 1, 2006 10:03 AM
As I wrote, you can get rid of IP in pharmaceuticals as long as you get rid of the government regulations, but I do agree that getting rid of IP alone would largely shut down pharmaceutical research in the private sector.
Published: June 1, 2006 10:17 AM
Therefore, we have a utilitarian case to justify the initiation of force (or threat thereof),
You can’t establish that it’s an initiation of force until you establish that the IP owner is not the just owner of that right, i.e., beg the question.
Isn’t that your position? How did I take it out of context?
A number of ways. First, in the part of my post you were responding to I was only debunking the WHO’s CBA, not defending utilitarianism. Second, I’m not invoking utilitarianism, but consequentialism, its superset. Third, as above, you begged the question.
Yancey_Ward:
You clearly know almost nothing about drug research.
No, I disagree with your underlying assumptions. I’m aware of them, I just disagree. Let’s see if we can’t lay off the vindictive.
FDA regulations are what drives the costs of drug research… They are *part* of it, sure, but I disagree about how much. On a market without their regulations, you would still want drug certification. You could still sell the uncertified drug with no guarantee whatsoever of a payment if it kill or hurts you; I just doubt that this market is as lucrative, or the drug able to secure a higher price, as you seem to think. The private drug certification/ insurance would of course be cheaper than the bureaucratic FDA, I doubt this is more than an order of magnitude. The fact remains that drug research would still be really really expensive. And like I said to you a month ago, even if it were “only” $50 million and 5 years to develop the drug, once researchers flush out the lowest-hanging fruit, they’ll go into the harder stuff, where it will be more expensive, due to the research’s difficulty.
Published: June 1, 2006 10:59 AM
Published: June 1, 2006 11:25 AM
Published: June 1, 2006 11:33 AM
You were claiming IP rights are not part of a “free market”, i.e., that a market respecting IP rights is not “free”. To that specific claim, you do not need to regress to consequentialist (not utilitarian — let’s see if I don’t need to remind you of the distinction a fourth time) concerns; you just need to rigorously define a free market so that it does include monopolies in physical property, but not intellectual property. Get it?
Published: June 1, 2006 11:36 AM
take utilitarian arguments and pretend they’re moral arguments.
Consequentialism and utilitarianism are theories of morality. I think you were looking for a different term.
If you support a utilitarian position (and the coercion it requires), don’t take shame in saying so.
Fourth time: there’s a difference between consequentialism and utilitarianism.
Frankly, if the pharmaceutical giants needed patents, they could form free-market contract associations to avoid copying each others’ drugs within a certain period of time. The market would determine the specifics. Everyone, including the customers, would win. Getting the state involved just screws everything up.
…?
The fact that your proposed “solution” involves cartelization should have been your first clue it’s unhelpful. How again do they stop people from copying others and undercutting them?
Published: June 1, 2006 11:41 AM
As for consequentialism vs utilitarianism, it doesn’t much matter to me what equation is used to come up with the collectivist justification for initiating force, so forgive me for applying the wrong name to it.
Published: June 1, 2006 1:03 PM
Published: June 1, 2006 1:12 PM
“How again do they stop people from copying others and undercutting them?”
By joining a trade association and agreeing to those rules. Obviously, they can’t coerce behaviour from companies outside the association; but if UP were truly mutually beneficial, all major players would device a contractual system to replace the state’s arbitrary system.
Would such an association form, or would pharmaceuticals find it more profitable to compete on all levels? One can’t know until the laws are relaxed.
Published: June 2, 2006 3:59 AM
Published: August 4, 2006 8:54 AM
Published: August 4, 2006 9:59 AM
If both patents and the FDA were abolished simultaneously, Consumer Reports would cover the effectiveness portion, while UL would cover the safety portion.
With the cost of getting a pill to market then approaching the unit cost of manufacture, I would wager there would be MORE lifesaving drugs brought to market without patents, not fewer.
Published: August 4, 2006 2:57 PM
You seem to think that the testing phase would be completely non-existent if there were no FDA regulation. i.e., no one would bother testing their drugs before selling them to the public, and insurance underwriters/stockholders would “take their word for it” that the drug wouldn’t kill people or result in damage awards. Or, perhaps, you accept they’d still test drugs, but know some reason that the non-FDA free market testing costs would be so insignificant as to render patents superfluous, but didnt’ bother telling me the basis for this belief.
Another five minutes of my life wasted…
Published: August 4, 2006 4:03 PM
Published: April 10, 2008 11:18 AM